Catherine Thomas Cochran, PhD

Senior Research Specialist


Dr. Catherine Cochran

Contact

412-967-6599
Fax: 412-967-6545

W1144 Biomedical Science Tower

200 Lothrop Street

Pittsburgh, PA 15261

Education

PhD in Toxicology, University of Pittsburgh, Graduate School of Public Health, 2003

BS in Chemistry/PreMed, Gannon University, 1996

Program

Environmental and Occupational Health (GSPH)

Mentor

Billy W. Day, PhD

Dissertation

Research Lab Affiliation

Areas of Interest

Urology; Immunology; Toxicology

Why I Chose Pitt

I chose the University of Pittsburgh because of its reputation and it is a place where I could see myself enjoying and succeeding at my studies.

Abstracts

  • Thomas (Cochran) CA, Masuda H, Hayashi Y, Marx S, de Miguel F, Yoshimura N, Chancellor MB. The Effect of Solabegron, a Selective β3 Agonist, on Human Bladder Strips.  American Paraplegia Society (APS) annual meeting Las Vegas, Nevada, September 5-7, 2006 (Moderated Poster)
  • Thomas (Cochran) CA, Yoshimura N, Chancellor MB, de Miguel F.  The Effect of VR1 Antagonist in Chronic Spinal Cord Injured (SCI) Rats.  American Paraplegia Society (APS) annual meeting Las Vegas, Nevada, September 5-7, 2006 (Moderated Poster)
  • Thomas (Cochran) CA, Smith C, O’Leary M, Marx S, Erickson J, Chancellor MB.  Clinical Experience in Neurogenic Bladder Patients Treated with Botulinum Toxin Injection into Detrusor and Sphincter Simultaneously. Annual Cure-SCI meeting Pittsburgh, March 22, 2006 (Moderated Poster)
  • Thomas (Cochran) CA, Smith C, O’Leary M, Marx S, Erickson J, Chancellor MB. Bladder Submucosal Botulinum Toxin-A Injection Improves Voiding Symptoms and Pain in Interstitial Cystitis. Annual Cure-SCI meeting Pittsburgh, March 22, 2006 (Moderated Poster)
  • Smaldone MC, Smith C, O’Leary M, Thomas (Cochran) CA, Marx S, Erickson J, Chancellor MB. Safety and Efficacy of Bladder Botulinum Toxin Injection in the Elderly. Annual Cure-SCI meeting Pittsburgh, March 22, 2006 (Moderated Poster)
  • Thomas (Cochran) CA, Tyagi S, Masuda H, Yoshimura N, Chancellor MB, de Miguel F.  B-adrenoceptor mRNA in Human Urothelium and Detrusor Muscle. American Urological Association (AUA) annual meeting San Antonio, TX, May 21-26, 2005 (Moderated Poster Presentation)
  • Tyagi S, Van Le T, Thomas (Cochran) CA, Masuda H, Stein RJ, Yoshimura N, Chancellor MB, de Miguel F. Differentiation Stage-Specific Expression Patterns Of Muscarinic Receptors 1-5 mRNA In Urothelium And Detrusor of Human Bladder. American Urological Association (AUA) annual meeting San Antonio, TX, May 21-26, 2005 (Moderated Poster Presentation)
  • Thomas (Cochran) CA, Latimer JJ, Sussman NB, Gomez J, Macina OT, Grant SG, Mattison DR. Toxic and Teratogenic Effects of Retinoic Acid in the Developing Mouse Model.  University of Pittsburgh, Graduate School of Public Health Dean’s Day, 1999.  (Moderated Poster Presentation)

Publications

Tyagi, P; Thomas, C. A; Yoshimura, N; and Chancellor, M. B. (2009) Investigations into the presence of functional Beta1, Beta2 and Beta3-adrenoceptors in urothelium and detrusor of human bladder. Int Braz J Urol. 35: 76-83. |  View Abstract

Thomas, C. A; Grant, S. G; Pflug, B. R; Getzenberg, R. H; and Day, B. W. (2008) (Z)-1,1-Dichloro-2-(4-methoxyphenyl)-3-phenylcyclopropane induces concentration-dependent growth inhibition, apoptosis, and coordinates regulation of apoptotic genes in TRAMP cells. Urol Oncol. 26: 378-385. |  View Abstract

Chuang, Y. C; Thomas, C. A; Tyagi, S; Yoshimura, N; Tyagi, P; and Chancellor, M. B. (2008) Human urine with solifenacin intake but not tolterodine or darifenacin intake blocks detrusor overactivity. Int Urogynecol J Pelvic Floor Dysfunct. 19: 1353-1357. |  View Abstract

Thomas, C. A; Tyagi, S; Yoshimura, N; Chancellor, M. B; and Tyagi, P. (2007) Effect of hyperforin-enriched extract on pro-ejaculatory effect of 8-hydroxy-2-(di-N-propylamino)tetralin in anesthetized rats. Urology. 70: 813-816. |  View Abstract

Thomas, C; Kim, J. H; Torimoto, K; Kwon, D. D; Kim, Y. T; Tyagi, P; Yoshimura, N; and Chancellor, M. B. (2007) Early capsaicin intervention for neurogenic bladder in a rat model of spinal cord injury. Biomed Res. 28: 255-259. |  View Abstract

Thomas, C. A; Guercini, F; Chuang, Y. C; and Chancellor, M. B. (2006) Botulinum-A toxin: an exciting new treatment option for prostatic disease. Int J Clin Pract Suppl. 151: 33-37. |  View Abstract

Thomas, C. A; Chuang, Y. C; Giannantoni, A; and Chancellor, M. B. (2006) Botulinum A toxin for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms. Curr Urol Rep. 7: 266-271. |  View Abstract